Daniel G. Salvadori

2020

In 2020, Daniel G. Salvadori earned a total compensation of $6M as Executive Vice President, Nutritional Products at Abbott Laboratories, a 12% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$477,011
Non-Equity Incentive Plan$905,500
Option Awards$1,902,099
Salary$710,000
Stock Awards$1,901,708
Other$79,421
Total$5,975,739

Salvadori received $1.9M in option awards, accounting for 32% of the total pay in 2020.

Salvadori also received $477K of change in pension value and nonqualified deferred compensation earnings, $905.5K in non-equity incentive plan, $710K in salary, $1.9M in stock awards and $79.4K in other compensation.

Rankings

In 2020, Daniel G. Salvadori's compensation ranked 1,744th out of 13,090 executives tracked by ExecPay. In other words, Salvadori earned more than 86.7% of executives.

ClassificationRankingPercentile
All
1,744
out of 13,090
87th
Division
Manufacturing
666
out of 5,617
88th
Major group
Chemicals And Allied Products
238
out of 2,248
89th
Industry group
Drugs
199
out of 1,948
90th
Industry
Pharmaceutical Preparations
139
out of 1,453
90th

Pay ratio

Daniel G. Salvadori's Pay$5,975,739
Median Employee's Pay$77,594
Pay Ratio

77

to 1

In 2020, the annual total compensation of Daniel G. Salvadori was $5,975,739.

The annual total compensation of the median employee at Abbott Laboratories was $77,594.

The ratio of Daniel G. Salvadori's pay to the pay of median employee was therefore 77 to one.

Source: SEC filing on March 12, 2021.

Salvadori's colleagues

We found six more compensation records of executives who worked with Daniel G. Salvadori at Abbott Laboratories in 2020.

2020

Robert Ford

Abbott Laboratories

Chief Executive Officer

2020

Miles White

Abbott Laboratories

Chairman

2020

Robert Funck

Abbott Laboratories

Chief Financial Officer

2020

Hubert Allen

Abbott Laboratories

General Counsel

2020

John Ginascol

Abbott Laboratories

Executive Vice President, Core Diagnostics

2020

Brian Yoor

Abbott Laboratories

Chief Financial Officer

News

You may also like